Your browser doesn't support javascript.
loading
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.
Ladislau, Leandro; Suárez-Calvet, Xavier; Toquet, Ségolène; Landon-Cardinal, Océane; Amelin, Damien; Depp, Marine; Rodero, Mathieu P; Hathazi, Denisa; Duffy, Darragh; Bondet, Vincent; Preusse, Corinna; Bienvenu, Boris; Rozenberg, Flore; Roos, Andreas; Benjamim, Claudia F; Gallardo, Eduard; Illa, Isabel; Mouly, Vincent; Stenzel, Werner; Butler-Browne, Gillian; Benveniste, Olivier; Allenbach, Yves.
Afiliação
  • Ladislau L; Sorbonne Université, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
  • Suárez-Calvet X; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Toquet S; Sorbonne Université, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
  • Landon-Cardinal O; Neuromuscular Diseases Unit, Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona and Institut de Recerca Sant Pau, Barcelona, Spain.
  • Amelin D; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Depp M; Sorbonne Université, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
  • Rodero MP; Sorbonne Université, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
  • Hathazi D; Sorbonne Université, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
  • Duffy D; Laboratory of Neurogenetics and Neuroinflammation, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1163 and Université Paris Descartes, Université Sorbonne Paris Cité, Institut Imagine, 75015 Paris, France.
  • Bondet V; Laboratory of Neurogenetics and Neuroinflammation, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1163 and Université Paris Descartes, Université Sorbonne Paris Cité, Institut Imagine, 75015 Paris, France.
  • Preusse C; Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V, Biomedical Research Department, Tissue Omics group, Otto-Hahn-Str. 6b, 44227, Dortmund, Germany.
  • Bienvenu B; INSERM UMR 1223 and Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, Paris, France.
  • Rozenberg F; INSERM UMR 1223 and Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, Paris, France.
  • Roos A; Department of Neuropathology, Charité University, Berlin, Germany.
  • Benjamim CF; Department of Internal Medicine, Saint Joseph Hospital, Marseille, France.
  • Gallardo E; Departement de Virologie, Hôpital Cochin, Paris Descartes Universités, Paris, France.
  • Illa I; Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V, Biomedical Research Department, Tissue Omics group, Otto-Hahn-Str. 6b, 44227, Dortmund, Germany.
  • Mouly V; Institute of Genetic Medicine, John Walton Muscular Dystrophy Research Centre, International Centre for Life, Central Parkway, Newcastle upon Tyne, England, UK.
  • Stenzel W; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Butler-Browne G; Neuromuscular Diseases Unit, Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona and Institut de Recerca Sant Pau, Barcelona, Spain.
  • Benveniste O; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Allenbach Y; Neuromuscular Diseases Unit, Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona and Institut de Recerca Sant Pau, Barcelona, Spain.
Brain ; 141(6): 1609-1621, 2018 06 01.
Article em En | MEDLINE | ID: mdl-29741608
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Transdução de Sinais / Interferon Tipo I / Músculo Esquelético / Dermatomiosite / Inibidores de Janus Quinases Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Transdução de Sinais / Interferon Tipo I / Músculo Esquelético / Dermatomiosite / Inibidores de Janus Quinases Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França